Neos Therapeutics announces this week the recent approval of its pediatric ADHD medication, Cotempla. The medication is approved for use in children ages 6-17 years old. The tablet is an extended-release product which dissolves in the mouth, making regular use easier for young patients. Cotempla is the now the sixth dissolving extended-release treatment for ADHD on the U.S. market. Read the full press release here.